Welcome
Support Centre
12 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised double-blind prospective study to compare the intubating conditions with remifentanil (4 ug/mkg) and either propofol (2 mg/kg) or etomidate (0.3 mg/kg)
ISRCTN ISRCTN84400696
ClinicalTrials.gov identifier
Public title A randomised double-blind prospective study to compare the intubating conditions with remifentanil (4 ug/mkg) and either propofol (2 mg/kg) or etomidate (0.3 mg/kg)
Scientific title
Acronym N/A
Serial number at source N0084113942
Study hypothesis 1. To investigate whether there is a role for etomidate for intubation without muscle relaxants?
2. Is it more stable than propofol?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Intubation
Participants - inclusion criteria 40 American Society of Anesthesiologists (ASA) 1 and 2 non-obese (Body Mass Index [BMI] <30) elective surgical patients aged between 18 and 65 years. They must require intubation for their proposed surgery.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/08/2002
Anticipated end date 01/06/2004
Status of trial Completed
Patient information material
Target number of participants 40
Interventions 1. Remifentanil and etomidate
2. Remifentanil and propofol

Both the patients and the intubating anaesthetist will be blinded to the induction agents administered by a second anaesthetist.
Primary outcome measure(s) The end points are:
1. Intubating conditions
2. Cardiovascular stability
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The North and South Bank Research and Development Consortium (UK)
Trial website
Publications
Contact name Dr  Ian  McNeil
  Address Department of Anaesthesia
Hull Royal Infirmary
Anlaby Road
  City/town Hull
  Zip/Postcode HU3 2 JZ
  Country United Kingdom
  Email
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 21/01/2009
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central